<DOC>
	<DOCNO>NCT00624819</DOCNO>
	<brief_summary>This protocol post deal objective &amp; outcome measure extension phase 48-50 month post booster vaccination , assess long-term antibody persistence child around 30 , 42 66 month age , receive previously 4 dos pneumococcal conjugate vaccine . The objective &amp; outcome measure primary phase present separate protocol posting ( NCT number = 00307554 ) . This Protocol posting update order comply FDA AA ( Sep 2007 ) .</brief_summary>
	<brief_title>Assessment Antibody Persistence Children Previously Vaccinated With Pneumococcal Conjugate Vaccine</brief_title>
	<detailed_description>This study consist serological follow-up study evaluate persistence 12 , 24 48 month booster vaccination study ( 107046 ) . No study vaccine administer within study .</detailed_description>
	<mesh_term>Streptococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Male female , include , 2830 month age time first blood sample . Subjects previously participate 105553 107046 study receive full four dose regimen pneumococcal conjugate vaccine primary booster study . Subjects investigator believe parents/guardians comply requirement protocol . Written informed consent , cover visit 1 , 2 3 , obtain parent guardian subject . Free obvious health problem establish medical history clinical examination enter study . Chronic administration immunosuppressant immunemodifying drug within 6 month prior blood sample Administration additional pneumococcal vaccine since end 107046 study . Use investigational nonregistered product ( drug vaccine ) within 30 day precede blood sampling . Administration immunoglobulins and/or blood product less 6 month prior blood sample . Any confirm suspected immunosuppressive immunodeficient condition since end 107046 study , base medical history physical examination .</criteria>
	<gender>All</gender>
	<minimum_age>28 Months</minimum_age>
	<maximum_age>32 Months</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Streptococcus pneumoniae</keyword>
	<keyword>Haemophilus influenzae</keyword>
	<keyword>Pneumococcal conjugate vaccine</keyword>
	<keyword>Antibody persistence</keyword>
</DOC>